Literature DB >> 22723710

Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.

Tara L Martinez1, Lingling Kong, Xueyong Wang, Melissa A Osborne, Melissa E Crowder, James P Van Meerbeke, Xixi Xu, Crystal Davis, Joe Wooley, David J Goldhamer, Cathleen M Lutz, Mark M Rich, Charlotte J Sumner.   

Abstract

The inherited motor neuron disease spinal muscular atrophy (SMA) is caused by deficient expression of survival motor neuron (SMN) protein and results in severe muscle weakness. In SMA mice, synaptic dysfunction of both neuromuscular junctions (NMJs) and central sensorimotor synapses precedes motor neuron cell death. To address whether this synaptic dysfunction is due to SMN deficiency in motor neurons, muscle, or both, we generated three lines of conditional SMA mice with tissue-specific increases in SMN expression. All three lines of mice showed increased survival, weights, and improved motor behavior. While increased SMN expression in motor neurons prevented synaptic dysfunction at the NMJ and restored motor neuron somal synapses, increased SMN expression in muscle did not affect synaptic function although it did improve myofiber size. Together these data indicate that both peripheral and central synaptic integrity are dependent on motor neurons in SMA, but SMN may have variable roles in the maintenance of these different synapses. At the NMJ, it functions at the presynaptic terminal in a cell-autonomous fashion, but may be necessary for retrograde trophic signaling to presynaptic inputs onto motor neurons. Importantly, SMN also appears to function in muscle growth and/or maintenance independent of motor neurons. Our data suggest that SMN plays distinct roles in muscle, NMJs, and motor neuron somal synapses and that restored function of SMN at all three sites will be necessary for full recovery of muscle power.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22723710      PMCID: PMC3462658          DOI: 10.1523/JNEUROSCI.0204-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Authors:  Ferrill F Rose; Virginia B Mattis; Hansjörg Rindt; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

2.  Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.

Authors:  Lyndsay M Murray; Laura H Comley; Derek Thomson; Nick Parkinson; Kevin Talbot; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2007-12-08       Impact factor: 6.150

3.  Different autonomous myogenic cell populations revealed by ablation of Myf5-expressing cells during mouse embryogenesis.

Authors:  Nicole Gensch; Thilo Borchardt; Andre Schneider; Dieter Riethmacher; Thomas Braun
Journal:  Development       Date:  2008-03-26       Impact factor: 6.868

4.  Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.

Authors:  Shingo Kariya; Gyu-Hwan Park; Yuka Maeno-Hikichi; Olga Leykekhman; Cathleen Lutz; Marc S Arkovitz; Lynn T Landmesser; Umrao R Monani
Journal:  Hum Mol Genet       Date:  2008-05-20       Impact factor: 6.150

Review 5.  Regulation and function of skeletal muscle stem cells.

Authors:  M Cerletti; J L Shadrach; S Jurga; R Sherwood; A J Wagers
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-02-09

Review 6.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

7.  Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice.

Authors:  Lingling Kong; Xueyong Wang; Dong W Choe; Michelle Polley; Barrington G Burnett; Marta Bosch-Marcé; John W Griffin; Mark M Rich; Charlotte J Sumner
Journal:  J Neurosci       Date:  2009-01-21       Impact factor: 6.167

8.  Progenitors of skeletal muscle satellite cells express the muscle determination gene, MyoD.

Authors:  Onur Kanisicak; Julio J Mendez; Shoko Yamamoto; Masakazu Yamamoto; David J Goldhamer
Journal:  Dev Biol       Date:  2009-05-21       Impact factor: 3.582

9.  A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis.

Authors:  Masakazu Yamamoto; Nicole A Shook; Onur Kanisicak; Shoko Yamamoto; Michael N Wosczyna; James R Camp; David J Goldhamer
Journal:  Genesis       Date:  2009-02       Impact factor: 2.487

10.  Modeling spinal muscular atrophy in Drosophila.

Authors:  Howard Chia-Hao Chang; Douglas N Dimlich; Takakazu Yokokura; Ashim Mukherjee; Mark W Kankel; Anindya Sen; Vasanthi Sridhar; Tudor A Fulga; Anne C Hart; David Van Vactor; Spyros Artavanis-Tsakonas
Journal:  PLoS One       Date:  2008-09-15       Impact factor: 3.240

View more
  84 in total

1.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

2.  Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production.

Authors:  Jered V McGivern; Teresa N Patitucci; Joshua A Nord; Marie-Elizabeth A Barabas; Cheryl L Stucky; Allison D Ebert
Journal:  Glia       Date:  2013-07-10       Impact factor: 7.452

3.  Defects in Motoneuron-Astrocyte Interactions in Spinal Muscular Atrophy.

Authors:  Chunyi Zhou; Zhihua Feng; Chien-Ping Ko
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

4.  Hyperexcitability precedes motoneuron loss in the Smn2B/- mouse model of spinal muscular atrophy.

Authors:  K A Quinlan; E J Reedich; W D Arnold; A C Puritz; C F Cavarsan; C J Heckman; C J DiDonato
Journal:  J Neurophysiol       Date:  2019-07-31       Impact factor: 2.714

5.  The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.

Authors:  Constantin d'Ydewalle; Daniel M Ramos; Noah J Pyles; Shi-Yan Ng; Mariusz Gorz; Celeste M Pilato; Karen Ling; Lingling Kong; Amanda J Ward; Lee L Rubin; Frank Rigo; C Frank Bennett; Charlotte J Sumner
Journal:  Neuron       Date:  2016-12-22       Impact factor: 17.173

Review 6.  Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Authors:  Sarah Tisdale; Livio Pellizzoni
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

7.  Astrocytes influence the severity of spinal muscular atrophy.

Authors:  Hansjörg Rindt; Zhihua Feng; Chiara Mazzasette; Jacqueline J Glascock; David Valdivia; Noah Pyles; Thomas O Crawford; Kathryn J Swoboda; Teresa N Patitucci; Allison D Ebert; Charlotte J Sumner; Chien-Ping Ko; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2015-04-24       Impact factor: 6.150

8.  Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.

Authors:  Christian M Simon; Beatriz Blanco-Redondo; Jannik M Buettner; John G Pagiazitis; Emily V Fletcher; Josiane K Sime Longang; George Z Mentis
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

9.  SMN-targeted therapeutics for spinal muscular atrophy: are we SMArt enough yet?

Authors:  Kathryn J Swoboda
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  SMN is required for sensory-motor circuit function in Drosophila.

Authors:  Wendy L Imlach; Erin S Beck; Ben Jiwon Choi; Francesco Lotti; Livio Pellizzoni; Brian D McCabe
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.